Tag: Phase II trials

Tirzepatide + Apitegromab Preserves Lean Mass Better Than Tirzepatide + Placebo in Phase 2 EMBRAZE Study

June 9, 2026

Tirzepatide + Apitegromab Preserves Lean Mass Better Than Tirzepatide + Placebo in Phase 2 EMBRAZE Study

Trabectedin and Low-Dose Irinotecan Show Promise in Treating Ewing Sarcoma

April 17, 2026

Trabectedin and Low-Dose Irinotecan Show Promise in Treating Ewing Sarcoma

Competing Interests & Disclosures | Author Financial Relationships

March 1, 2026

Competing Interests & Disclosures | Author Financial Relationships

Web Analytics